Prognostic value of motor and extramotor involvement in ALS

References

• Masrori P, Van Damme P. Amyotrophic lateral sclerosis: a clinical review. Eur J Neurol. 2020;27:1918–29.
   PubMed Web of Science ®Google Scholar
• Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.
   PubMed Web of Science ®Google Scholar
• Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, et al. 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology 2016;86:44–9.
   PubMed Web of Science ®Google Scholar
• Beeldman E, Raaphorst J, Twennaar MK, De Visser M, Schmand BA, De Haan RJ. The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry. 2016;87:611–9.
   PubMed Web of Science ®Google Scholar
• Costello E, Rooney J, Pinto-Grau M, Burke T, Elamin M, Bede P, et al. Cognitive reserve in amyotrophic lateral sclerosis (ALS): a population-based longitudinal study. J Neurol Neurosurg Psychiatry. 2021;92:460–5.
   PubMed Web of Science ®Google Scholar
• Beeldman E, Jaeger B, Raaphorst J, Seelen M, Veldink J, Van Den Berg L, et al. The verbal fluency index: Dutch normative data for cognitive testing in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:388–91.
   PubMed Web of Science ®Google Scholar
• De Icaza Valenzuela MM, Bak TH, Thompson HE, Colville S, Pal S, Abrahams S. Validation of The Edinburgh cognitive and behavioural ALS screen (ECAS) in behavioural variant frontotemporal dementia and Alzheimer’s disease. Int J Geriatr Psychiatry. 2021;36:1576–87.
   PubMed Web of Science ®Google Scholar
• Westeneng HJ, Debray TPA, Visser AE, van Eijk RPA, Rooney JPK, Calvo A, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423–33.
   PubMed Web of Science ®Google Scholar
• Reniers W, Schrooten M, Claeys KG, Tilkin P, D'Hondt A, Van Reijen D, et al. Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:341–50.
   PubMed Web of Science ®Google Scholar
• Xu Z, Alruwaili ARS, Henderson RD, McCombe PA. Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: frequency of abnormality and effect on survival. J Neurol Sci. 2017;376:16–23.
   PubMed Web of Science ®Google Scholar
• Ye S, Jin P, Chen L, Zhang N, Fan D. Prognosis of amyotrophic lateral sclerosis with cognitive and behavioural changes based on a sixty-month longitudinal follow-up. PLoS One. 2021;16:e0253279.
   PubMed Web of Science ®Google Scholar
• Nguyen C, Caga J, Mahoney CJ, Kiernan MC, Huynh W. Behavioural changes predict poorer survival in amyotrophic lateral sclerosis. Brain Cogn 2021;150:105710.
   PubMed Web of Science ®Google Scholar
• Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, et al. Behavior matters-cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One. 2013;8:e57584.
   PubMed Web of Science ®Google Scholar
• Devine MS, Ballard E, O'Rourke P, Kiernan MC, Mccombe PA, Henderson RD. Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2016;17:184–90.
   PubMed Web of Science ®Google Scholar
• Fujimura-Kiyono C, Kimura F, Ishida S, Nakajima H, Hosokawa T, Sugino M, et al. Onset and spreading patterns of lower motor neuron involvements predict survival in sporadic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82:1244–9.
   PubMed Web of Science ®Google Scholar
• Zakharova MN, Abramova AA. Lower and upper motor neuron involvement and their impact on disease prognosis in amyotrophic lateral sclerosis. Neural Regen Res. 2022;17:65–73.
   PubMed Web of Science ®Google Scholar
• Kjældgaard AL, Pilely K, Olsen KS, Jessen AH, Lauritsen AØ, Pedersen SW, et al. Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study. BMC Neurol. 2021;21:164.
   PubMed Web of Science ®Google Scholar
• Chiò A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, et al. Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology 2019;93:E984–e994.
   PubMed Web of Science ®Google Scholar
• Crockford C, Newton J, Lonergan K, Chiwera T, Booth T, Chandran S, et al. ALS-specific cognitive and behavior changes associated with advancing disease stage in ALS. Neurology 2018;91:E1370–e1380.
   PubMed Web of Science ®Google Scholar
• Canosa A, Moglia C, Manera U, Vasta R, Torrieri MC, Arena V, et al. Metabolic brain changes across different levels of cognitive impairment in ALS: a 18 F-FDG-PET study. J Neurol Neurosurg Psychiatry 2021;92:357–63.
   Web of Science ®Google Scholar
• Bakker LA, Schröder CD, Spreij LA, Verhaegen M, De Vocht J, Van Damme P, et al. Derivation of norms for the Dutch version of the Edinburgh cognitive and behavioral ALS screen. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20:19–27.
   PubMed Web of Science ®Google Scholar
• Strong MJ, Abrahams S, Goldstein LH, Woolley S, Mclaughlin P, Snowden J, et al. Amyotrophic lateral sclerosis—frontotemporal spectrum disorder (ALS-FTSD): revised diagnostic criteria. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18:153–74.
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134:2456–77.
   PubMed Web of Science ®Google Scholar
• Rusina R, Vandenberghe R, Bruffaerts R. Cognitive and behavioral manifestations in ALS: beyond motor system involvement. Diagnostics 2021;11:624.
   Web of Science ®Google Scholar
• Ahmed RM, Devenney EM, Strikwerda-Brown C, Hodges JR, Piguet O, Kiernan MC. Phenotypic variability in ALS-FTD and effect on survival. Neurology 2020;94:E2005–e2013.
   PubMed Web of Science ®Google Scholar
• Caga J, Hsieh S, Lillo P, Dudley K, Mioshi E. The impact of cognitive and behavioral symptoms on ALS patients and their caregivers. Front Neurol. 2019;10:192.
   PubMed Web of Science ®Google Scholar
• Chio A, Ilardi A, Cammarosano S, Moglia C, Montuschi A, Calvo A. Neurobehavioral dysfunction in ALS has a negative effect on outcome and use of PEG and NIV. Neurology 2012;78:1085–9.
   PubMed Web of Science ®Google Scholar